Cargando…
Precision medicine for metastatic colorectal cancer in clinical practice
Globally, metastatic colorectal cancer is one of the leading causes for cancer-related death. Treatment limited to conventional chemotherapeutics extended life for only a few months. However, advances in surgical approaches and medical treatment regimens have greatly increased survival, even leading...
Autores principales: | Riedesser, Julian E., Ebert, Matthias P., Betge, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882813/ https://www.ncbi.nlm.nih.gov/pubmed/35237350 http://dx.doi.org/10.1177/17588359211072703 |
Ejemplares similares
-
Towards the era of precision medicine in metastatic colorectal cancer
por: Napolitano, Stefania, et al.
Publicado: (2020) -
Lymph node retrieval in colorectal cancer: determining factors and prognostic significance
por: Betge, Johannes, et al.
Publicado: (2017) -
Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene
por: Torres-Jiménez, Javier, et al.
Publicado: (2022) -
MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016) -
Cancer-Associated Mutations in Normal Colorectal Mucosa Adjacent to Sporadic Neoplasia
por: Zhan, Tianzuo, et al.
Publicado: (2020)